Skip to content

PARTNER II: Improving Patient and Family Centered Care in Advanced Critical Illness

Stepped Wedge Trial of an Intervention to Support Proxy Decision Makers in ICUs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02445937
Enrollment
848
Registered
2015-05-15
Start date
2015-06-01
Completion date
2019-09-18
Last updated
2019-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

decision making for incapacitated patients, intensive care, surrogate decision making, patient centered care, palliative care

Brief summary

This is a stepped wedged randomized controlled trial comparing the PARTNER intervention with usual care in 5 Intensive Care Units. The overarching goal of this research project to ensure patient-centered decisions about the use of intensive treatments for patients with advanced critical illness. In a prior project, the investigators developed the PARTNER program (PAiring Re-engineered ICU Teams with Nurse-driven Education and OutReach), a 4-facet, team-based intervention that re-engineers how surrogates are supported in ICUs, including: 1) changing care defaults to ensure clinician-family meetings within 48 hours of enrollment and frequently thereafter; 2) protocolized, nurse-administered coaching and emotional support of surrogates before and during clinician-family meetings, 3) increased use of palliative care services for patients with a poor prognosis. The investigators propose to begin deployment of the PARTNER II program in the spring of 2015 enrolling 690 surrogate decision makers in 5 ICUs using a stepped wedge design. The investigators expect to achieve the following project goals: 1. To increase the patient-centeredness of end-of-life decisions, and to increase the quality of clinician-family communication. 2. To decrease the psychological burden on family members acting as surrogates. 3. To reduce total health care costs by decreasing the duration of use of burdensome, invasive treatments at the end of life.

Interventions

BEHAVIORALPARTNER II

The PARTNER intervention is a multifaceted intervention delivered by a trained PARTNER Champion who has undergone 16 hours of intense communication training, with audit and feedback, quarterly booster training, and expert implementation support. Additionally, there is academic detailing of ICU physicians and ICU bedside nurses to augment the intervention. The PARTNER Intervention deploys three strategies to improve: 1) the timeliness and frequency of clinician-family communication, 2) the emotional and decision support provided to families and 3) the appropriate involvement of palliative care specialists.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Stepped Wedge Design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Surrogate decision maker for ICU patient in one of 5 UPMC ICU's

Exclusion criteria

* Non-English Speaking * Surrogate's loved one is for organ transplantation * Not physically able to participate in family meeting

Design outcomes

Primary

MeasureTime frameDescription
Quality of Communication (QOC) scaleAt 6 monthsWe will assess quality of communication in family members in a telephone interview 6 months after enrollment using the validated13 item Quality of Communication Scale.

Secondary

MeasureTime frameDescription
Patient-Centeredness of Care ScaleAt 6 monthsWe will assess Patient Centeredness of Care, using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted for use by surrogates.
Intensive Care Unit Length of StayParticipants will be followed for duration of ICU stay, an expected average of 21 daysWe will assess the Intensive Care Unit length of stay as assessed by abstraction of this information from the medical record.
Impact of Events ScaleAt 6 monthsWe will assess symptoms of post-traumatic stress in family members in a telephone interview 6 months after enrollment using the validated 22 item Impact of Events Scale.
Decision Regret ScaleAt 6 monthsWe will assess Decisional Regret by family members in a telephone interview 6 months after enrollment using the validated 5 item Decision Regret Scale across treatment groups.
Hospital Anxiety and Depression ScaleAt 6 monthsWe will assess symptom burden of anxiety and depression in family members in a telephone interview 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).

Other

MeasureTime frameDescription
MortalityAt 6 monthsWe will assess hospital mortality and 6-month mortality using hospital records, 6 month follow-up with surrogates, and the National Death Index in cases in which participants are lost to telephone follow up.
Katz Activities of Daily Living ScaleAt 6 monthsWe will assess functional status of the patient using the validated Katz Activities of Daily Living Scale at 6 months.
Hospital Length of StayParticipants will be followed for duration of hospital stay, an expected average of 4 weeks.We will assess hospital length of stay by abstraction of this information from the medical record at hospital discharge.
Total Hospitalization costsInclusive of index hospitalizationWe will measure total hospitalization costs by aggregating each patient's total service specific costs, generated from hospital administrative records.
6-month health care utilizationInclusive of index hospitalization and 6 months follow upWe will assess patient health care utilization using hospital records and through validated methods to assess utilization using standardized interviews with surrogates at 6 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026